No information is available on the clinical use of inclisiran during breastfeeding. Because inclisiran is a large oligonucleotide, the amount in milk is likely to be very low and absorption by the infant is probably minimal. If inclisiran is required by the mother, it is not a reason to discontinue breastfeeding. Until more data become available, inclisiran should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Cholestyramine, Colesevelam, Colestipol
Substance Identification
Substance Name
Inclisiran
CAS Registry Number
1639324-58-5
Drug Class
Breast Feeding
Lactation
Milk, Human
Anticholesteremic Agents
Antilipemic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
